ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0387

Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity

Marta Ibañez Martinez1, Sonia Pastor Navarro2, Olga Compán Fernández2, Belén Miguel Ibáñez2, Ana Isabel Turrión Nieves2, Susana Gómez Castro1, Olga Martínez González2, Cristina Hidalgo Calleja2, Esther Toledano Martinez3 and Carlos Montilla Morales2, 1Hospital Universitario Salamanca, Salamanca, Spain, 2Hospital Universitario de Salamanca, Salamanca, Spain, 3Hospital Clínico San Carlos, Madrid, Spain

Meeting: ACR Convergence 2022

Keywords: Comorbidity, Disease Activity, Psoriatic arthritis, sleep, Spondyloarthropathies

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: To evaluate the quality of sleep in patients with psoriatic arthritis (PsA) and its relationship with/to clinical variables, activity, functionality, the impact of the disease, and emotional factors.

Methods: It is a cross-sectional study involving 247 patients diagnosed with psoriatic arthritis. Sleep quality was measured using the PSQI questionnaire. Bivariate correlations were performed between PSQI, gender, number of affected entheses, PASI, peripheral activity (cDAPSA), axial activity (ASDAS-CRP and BASDAI), functionality (BASFI and HAQ), disease impact (PsAID), anxiety, depression (HADS) and fatigue (FACITfatigue). Significant cDAPSA variables, FACIT-F, HADS-A and HADS-D were included in a multiple linear regression model. On the other hand, the PSQI variable was categorized according to the cut-off point PSQI < 6 (good sleep quality) or PSQI ≥ 6 (poor sleep quality).Univariate analysis was performed with baseline variables, disease activity, and the different PROS included between the two groups of patients. Stepwise logistic regression, adjusted for female gender and presence of fibromyalgia, included the significant components of cDAPSA, FACIT-F, HADS-A, and HADS-D as independent variables and PSQI categorization as dependent variable.

Results: 63.15% had poor sleep quality. Of these patients, 46.5% were not taking treatment for insomnia. Female patients with a higher number of affected entheses, higher peripheral and axial activity, fatigue, anxiety, or depression had worse sleep quality. The PSQI was also related to the functionality and impact of the disease. The results are shown in the table. Multiple linear regression modelling revealed that pain [b: 0.48, p< 0.001] and fatigue [b:-0.13, p< 0.001, 95%CI] contributed 43% to the sleep quality pattern. In logistic regression, pain (OR: 1.20 [1.01-1.43)], fatigue [OR: 0.89 (0.84, 0.95)] and anxiety [OR: 1.27 (1.06-1.51)] accounted for 48% of poor sleep quality (PSQI ≥ 6).

Conclusion: Poor sleep quality was frequent in patients with PsA, despite which almost half did not perform any treatment. Emotional factors (fatigue, anxiety) were more relevant than inflammatory factors on sleep quality. The circular relationship between sleep quality, emotional disorders, and activity makes a multidisciplinary approach to the disease necessary.

Supporting image 1

Correlation coefficients between the PSQI and demographic, clinical variables and PROs and index of disease activity, functionality, and impact.


Disclosures: M. Ibañez Martinez, None; S. Pastor Navarro, None; O. Compán Fernández, None; B. Miguel Ibáñez, None; A. Turrión Nieves, None; S. Gómez Castro, None; O. Martínez González, None; C. Hidalgo Calleja, None; E. Toledano Martinez, None; C. Montilla Morales, None.

To cite this abstract in AMA style:

Ibañez Martinez M, Pastor Navarro S, Compán Fernández O, Miguel Ibáñez B, Turrión Nieves A, Gómez Castro S, Martínez González O, Hidalgo Calleja C, Toledano Martinez E, Montilla Morales C. Sleep Quality in Patients with Psoriatic Arthritis and Its Relationship with Activity and Comorbidity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/sleep-quality-in-patients-with-psoriatic-arthritis-and-its-relationship-with-activity-and-comorbidity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sleep-quality-in-patients-with-psoriatic-arthritis-and-its-relationship-with-activity-and-comorbidity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology